End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
137.8 CNY | -0.20% | +0.79% | +1.61% |
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- With an expected P/E ratio at 33.55 and 25.15 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company appears highly valued given the size of its balance sheet.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+1.61% | 2.66B | - | ||
+6.11% | 105B | A- | ||
-4.67% | 63.83B | A- | ||
+73.81% | 45.28B | B | ||
+15.46% | 38.93B | B | ||
+5.25% | 33.06B | A- | ||
+11.65% | 20.21B | B- | ||
+13.74% | 16.94B | C+ | ||
+20.05% | 16.08B | B- | ||
+5.02% | 14.49B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- 688281 Stock
- Ratings Shaanxi Huaqin Technology Industry Co.,Ltd.